FAIR LAWN, N.J., Nov. 14 /PRNewswire-FirstCall/ -- Vyteris Holdings (Nevada), Inc. will present at the 28th Annual Westergaard SmallCap Conference hosted by Paulson Investment Company, Inc. and Dutton Associates. Vyteris President and Chief Executive Officer Vincent De Caprio, Ph.D. will provide an update on business activities, trends and current developments.
The conference will take place at the Waldorf-Astoria in New York City on Monday, November 21, 2005 from 8 a.m. to 5 p.m. To listen to the presentation via phone please dial 800-862-9098 or 785-424-1051 between 9:05 a.m. and 9:30 a.m. ET or 11:25 a.m. and 11:50 a.m. ET. Lawrence Kudlow, CNBC commentator and co-host of "Kudlow & Company," is the conference's luncheon keynote speaker. For more conference information, visit http://www.westergaardsmallcap.com .
About Vyteris, Inc.
Vyteris Holdings (Nevada), Inc. is a specialty pharmaceutical company organized to develop and manufacture pharmaceutical products based upon its advanced drug delivery technology. The Company's Actyve(TM) transdermal drug delivery (iontophoresis) technology delivers drugs comfortably through the skin using low-level electrical energy. This technology allows precise dosing, thus providing physicians and patients with control in the rate, dosage and pattern of delivery. The Company's LidoSite(TM) product provides dermal analgesia prior to venipuncture (IV catheter insertions, blood draws, etc.) and superficial dermatological procedures. LidoSite(TM) received marketing clearance from the U.S. Food and Drug Administration and is marketed by B. Braun Medical Inc. For more information visit http://www.vyteris.com .
LidoSite(TM) is a trademark of B. Braun Medical, Inc.
Actyve(TM) is a trademark of Vyteris Holdings (Nevada), Inc.
Vyteris Holdings (Nevada), Inc.CONTACT: Michael G. McGuinness, Chief Financial Officer of VyterisHoldings (Nevada), Inc., +1-201-703-2418; Melody A. Carey, investors, of RxCommunications Group, LLC, +1-917-322-2571, mcarey@rxir.com
